您的购物车当前为空
HBX 19818 是一种特异性泛素特异性蛋白酶 7 (USP7) 抑制剂,IC50值为 28.1 μM。


为众多的药物研发团队赋能,
让新药发现更简单!
HBX 19818 是一种特异性泛素特异性蛋白酶 7 (USP7) 抑制剂,IC50值为 28.1 μM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 297 | In stock | |
| 5 mg | ¥ 942 | In stock | |
| 10 mg | ¥ 1,530 | In stock | |
| 25 mg | ¥ 2,550 | In stock | |
| 50 mg | ¥ 3,550 | In stock | |
| 100 mg | ¥ 4,970 | In stock | |
| 200 mg | ¥ 6,680 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 987 | In stock |
HBX 19818 相关产品
| 产品描述 | HBX 19818 is a specific ubiquitin-specific protease 7 (USP7) inhibitor (IC50: 28.1 μM). |
| 靶点活性 | USP7:28.1 μM |
| 体外活性 | HBX 19818 inhibits HCT116 proliferation in a dose-dependent manner (IC50: ~2 μM). HBX 19818 selectively inhibits USP7 (IC50: ~6 μM in human cancer cells). HBX 19818 (1.5, 4, 12, 36, or 100 μM) inhibits USP7 deubiquitination of polyubiquitinated p53. HBX 19818 displays no effects on USP8, USP5, USP10, CYLD, UCH-L1, UCH-L3, or on SENP1, a SUMO protease (IC50s of > 200 μM). HBX 19818 (30 μM) also causes significantly higher levels of Mdm2 polyubiquitinated forms in USP7-overproducing HEK293 cells than those in DMSO-treated control cells. |
| 分子量 | 421.96 |
| 分子式 | C25H28ClN3O |
| CAS No. | 1426944-49-1 |
| Smiles | CN(CCCNC(=O)c1ccc2nc3CCCCc3c(Cl)c2c1)Cc1ccccc1 |
| 密度 | 1.206 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 20 mg/mL (47.40 mM), Sonication is recommended. | |||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.74 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容